Autologous T Cells Modified by Chimeric Antigen Receptor Targeting EpCAM for Clinical Research on Advanced Digestive System Malignancies
Latest Information Update: 19 Jun 2024
At a glance
- Drugs Danburstotug (Primary)
- Indications Colorectal cancer; Gastric cancer; Liver cancer; Pancreatic cancer
- Focus Adverse reactions; First in man
Most Recent Events
- 08 Feb 2024 Planned primary completion date changed from 30 Dec 2023 to 30 Dec 2024.
- 29 Jun 2023 New trial record
- 06 Jun 2023 Results (As of January 30, 2023, n=12 )presented at the 59th Annual Meeting of the American Society of Clinical Oncology